Literature DB >> 24274445

Enterohepatic Helicobacter other than Helicobacter pylori.

Beatriz Mateos-Muñoz, Julio Pérez-de-la-Serna, Antonio Ruiz-de-León, Blanca Serrano-Falcón, Sergio Casabona-Francés, Aurelio Velasco-Cerrudo, Enrique Rey-Díaz-Rubio.   

Abstract

The Helicobacter genus includes Gram negative bacteria which were originally considered to belong to the Campylobacter genus. They have been classified in a separate genus since 1989 because they have different biochemical characteristics, with more than 24 species having been identified and more still being studied.H. pylori is the best known. It has an important etiopathogenic role in peptic ulcer disease and gastric cancer. Enterohepatic Helicobacters (EHH) other than H. pylori colonize the bowel, biliary tree and liver of animals and human beings with pathogenic potential. The difficulties existing to correctly isolate these microorganisms limit the description of their true prevalence and of the diseases they cause. Many studies have tried to discover the different clinical implications of EHH. Diseases like chronic liver disease, autoimmune hepatitis, hepatocarcinoma, autoimmune hepatobiliary disease, biliary lithiasis, cholangiocarcinoma and gallbladder cancer, Meckel´s diverticulum, acute appendicitis and inflammatory bowel disease have been related with different EHH species with different results, although their prevalence is greater than in healthy subjects. However, these data are currently not sufficient to draw definitive conclusions. Finally, the best known role of EHH in bowel disease is production of acute and chronic diarrhea pictures initially referred to as Campylobacter. H. pullorum has been identified in patients with acute gastroenteritis. The correct identification of EHH as producers of infectious gastroenteritis is found in its antibiotic susceptibility. It is generally macrolide-susceptible and quinolone-resistant.

Entities:  

Mesh:

Year:  2013        PMID: 24274445     DOI: 10.4321/s1130-01082013000800006

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  7 in total

Review 1.  Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?

Authors:  Banchob Sripa; Raksawan Deenonpoe; Paul J Brindley
Journal:  Parasitol Int       Date:  2016-12-03       Impact factor: 2.230

2.  The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter.

Authors:  Raksawan Deenonpoe; Chariya Chomvarin; Chawalit Pairojkul; Yaowalux Chamgramol; Alex Loukas; Paul J Brindley; Banchob Sripa
Journal:  Asian Pac J Cancer Prev       Date:  2015

3.  Why does infection with some helminths cause cancer?

Authors:  Paul J Brindley; José M Correia da Costa; Banchob Sripa
Journal:  Trends Cancer       Date:  2015-11-01

Review 4.  Significance of dormant forms of Helicobacter pylori in ulcerogenesis.

Authors:  Vasiliy Ivanovich Reshetnyak; Tatiana Magomedalievna Reshetnyak
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

5.  Helicobacter cinaedi Bacteremia Mimicking a Flare of Systemic Lupus Erythematosus.

Authors:  Ruriko Nishida; Nobuyuki Shimono; Noriko Miyake; Yong Chong; Shinji Shimoda; Hiroshi Tsukamoto; Koichi Akashi
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

6.  Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease.

Authors:  Raksawan Deenonpoe; Eimorn Mairiang; Pisaln Mairiang; Chawalit Pairojkul; Yaovalux Chamgramol; Gabriel Rinaldi; Alex Loukas; Paul J Brindley; Banchob Sripa
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

Review 7.  Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease: A Meta-Analysis.

Authors:  Qiao Yu; Shenghong Zhang; Li Li; Lishou Xiong; Kang Chao; Bihui Zhong; Yuwen Li; Huiling Wang; Minhu Chen
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.